Mark A. Feinstein

Statistics

Publications

Citations

133

H-Index

Active since

2002

Affiliations

Johnson & Johnson (United States)(Current)

Mark A. Feinstein is an author at Johnson & Johnson (United States) specializing in pharmacology, histamine receptor pharmacology, and cholinergic pharmacology.

Publications per year

2002–2010

Publications

StructureâFunction Analysis of Urotensin II and Its Use in the Construction of a LigandâReceptor Working Model

William A. Kinney, Harold R. Almond, Jenson Qi et al. · Angewandte Chemie International Edition · 2002 · 85 citations

Pharmacy, Biochemistry, Pharmacology +17

Pre-clinical characterization of aryloxypyridine amides as histamine H3 receptor antagonists: Identification of candidates for clinical development

Michael A. Letavic, Leah Aluisio, John Atack et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 27 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +12

Heterocyclic replacement of the central phenyl core of diamine-based histamine H3 receptor antagonists

Devin M. Swanson, Chandra Shah, Brian Lord et al. · European Journal of Medicinal Chemistry · 2009 · 21 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +15

1–3 of 3